Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 180

Results For "NSE"

2390 News Found

One-dose HPV vaccine offers solid protection against cervical cancer
News | April 12, 2022

One-dose HPV vaccine offers solid protection against cervical cancer

This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls


Pharmapack Europe 2022 to open on May 18-19 in Paris
Packaging | April 12, 2022

Pharmapack Europe 2022 to open on May 18-19 in Paris

Pharmapack trends are a key barometer of global device and packing opportunities in 2022


New very-high-sensitivity rapid antigen test kits hit Australian market
News | April 11, 2022

New very-high-sensitivity rapid antigen test kits hit Australian market

New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia


Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule
Biotech | April 11, 2022

Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule

GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology


Israel’s TAU breakthrough offers new hope to help people with paralysis walk again
News | April 11, 2022

Israel’s TAU breakthrough offers new hope to help people with paralysis walk again

Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant


Lonza signs manufacturing deal with Asher Biotherapeutics
Biotech | April 11, 2022

Lonza signs manufacturing deal with Asher Biotherapeutics

Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein


Moderna kickstarts Phase 1/2 study for influenza vaccine candidate
Biotech | April 11, 2022

Moderna kickstarts Phase 1/2 study for influenza vaccine candidate

Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle


New research on drug-induced gene signatures for colorectal cancer patients
Biotech | April 10, 2022

New research on drug-induced gene signatures for colorectal cancer patients

Data to be presented at the 2022 AACR annual meeting highlights the unique nature of post-chemotherapy derived gene expression signatures in stratifying patient outcomes


Data indicates homeopathy effective in management of long Covid
News | April 10, 2022

Data indicates homeopathy effective in management of long Covid

Dr. Kalyan Banerjee's Clinic developed a homeopathy prophylaxis protocol for the prevention of Covid-19 as soon as the pandemic began


Masina hospital launches a tobacco cessation clinic
Hospitals | April 10, 2022

Masina hospital launches a tobacco cessation clinic

The hospital is committed to adding to specialised practices in the healthcare space with its pioneering effort to promote oral health awareness and tobacco addiction prevention